PATENT CLAIM ANALYSIS

Application Number: 15938961
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "130100"]

Abstract:
The present invention relates to anti-AXL antibodies, immunoconjugates, compositions and method of treatment of cancer with such anti-AXL antibodies, immunoconjugates, or compositions.

Claim (Index 10):
An immunoconjugate comprising the antibody of  claim 1 , and a therapeutic moiety.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.42105
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15325364', '15533049', '15318023', '15318028', '14355986']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7467215594289802
- 35 USC 102 Novelty (BERT): 0.6416639795803935
- Combined Prediction Score: 0.7362158014441216
- Mean Citation Score: 488.148804
- Max Citation Score: 670.65137
- Similarity Product: 545.326602739929

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test